arrow_back Entities

PEBBLE BIOTECHNOLOGY LABORATORIES LTD

active Private Limited Company
πŸ‡¬πŸ‡§ GB | Incorporated 2018-03-27 | Reg. 11278041 | Data as of 2026-06-01
72110 - Research and experimental development on biotechnology

PEBBLE BIOTECHNOLOGY LABORATORIES LTD is a private limited company registered in the United Kingdom, under 11278041, incorporated on 27 March 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 8 years. Registered office address: SK9 4LD Wilmslow, the United Kingdom. Formerly known as PERFUSION BIOTECHNOLOGY LTD. Directors include MR MARK ROY CLAYDON, DR JAMES EDWARD FILDES, and DR LESLIE JAMES RUSSELL, and 1 other. Sole shareholder is DR JAMES EDWARD FILDES. Associated with 9 related entities, including 11268933, THE PEBBLE INSTITUTE CIC, and OC402805. The overall risk score is 0/100 (negligible). Confirmation statement overdue. Data sourced from UK Companies House.

bookmark_add Save this entity to a watchlist Β· Get alerts on changes Β· API access
Sign up free

Official Identifiers

REGISTRATION NUMBER 11278041

Name Registry

FORMER

PERFUSION BIOTECHNOLOGY LTD

FORMER

PERFUSION RESEARCH LTD

Registered Address

122, BEECH COURT HOLLIN LANE
STYAL
SK9 4LD WILMSLOW
the United Kingdom

Entity Risk Evaluation

0/100
negligible

Signal Intelligence (1)

Type Severity Description Detected
confirmation overdue MEDIUM Confirmation statement overdue β€”

Key Management & Controllers

DIRECTOR
50-75% DIRECTOR SHAREHOLDER
DIRECTOR

Associated Entities

Companies sharing one or more directors or officers with this entity.

πŸ‡¬πŸ‡§ 11268933
πŸ‡¬πŸ‡§ THE PEBBLE INSTITUTE CIC
πŸ‡¬πŸ‡§ OC402805
πŸ‡¬πŸ‡§ 12601510
πŸ‡¬πŸ‡§ STIMOXYGEN LTD
πŸ‡¬πŸ‡§ 04744791
πŸ‡¬πŸ‡§ 06272609

Change Log (5)

Date Change Details
2026-04-20 DIRECTOR ADDED Dr Leslie James Russell (director)
2026-04-20 DIRECTOR ADDED Dr James Edward Fildes (director)
2026-04-20 DIRECTOR ADDED Mark Roy Claydon (director)
2026-04-20 DIRECTOR ADDED Douglas Colin Walter Stellman (director)
2026-04-20 RISK SIGNAL ADDED Confirmation statement overdue

Source Records (1)

companieshouse 11278041 2026-06-01 open_in_new
Save entities, get alerts on changes, API access Sign up free